Brief: Sun Pharma and Almirall signs license deal for Psoriasis treatment

Sun Pharma Advanced Research

28/07/2016 03:32

July 27 (Reuters) - Sun Pharmaceutical Industries Ltd  SUN.NS : 
 * Almirall and Sun Pharma enter into a license agreement for Tildrakizumab in 
   Europe for Psoriasis 
 * To receive development & regulatory milestone payments, royalties, the terms 
   of which are confidential 
 
 * Source text: (http://bit.ly/2aihV1Q) 
 
 * Further company coverage  SPRC.NS  
 ((Bengaluru Newsroom; +91 80 6749 1130))